Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Antiprotozoal Agents01:21

Antiprotozoal Agents

Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Blood eosinophils: The forgotten man of inhaled steroid dose titration.

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology·2017
Same author

Cardiopulmonary interactions with beta-blockers and inhaled therapy in COPD.

QJM : monthly journal of the Association of Physicians·2017
Same author

Bronchoprotective tolerance with indacaterol is not modified by concomitant tiotropium in persistent asthma.

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology·2017
Same author

Effects of the inverse alpha-agonist doxazosin in allergic rhinitis.

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology·2016
Same author

From mouse to man: predicting biased effects of beta-blockers in asthma.

British journal of pharmacology·2015
Same author

Inhaled treatment for chronic obstructive pulmonary disease: what's new and how does it fit?

QJM : monthly journal of the Association of Physicians·2015

相关实验视频

Updated: Jul 5, 2026

Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries
08:49

Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries

Published on: January 22, 2019

利可特里因受体对抗剂 利可特里因受体对抗剂

B J Lipworth1

  • 1Department of Clinical Pharmacology & Therapeutics, Ninewells Hospital and Medical School, University of Dundee, UK. b.j.lipworth@dundee.uk

Lancet (London, England)
|February 19, 1999
PubMed
概括

胰岛素受体对抗剂为喘提供了一种新,方便的口服治疗方法,同时作为抗炎和支气管扩展剂. 这些药物还显示出对管理过敏性鼻炎的希望,这种过敏性鼻炎经常与喘同时发生.

科学领域:

  • 药理学 药理学是指药理学的学科.
  • 呼吸系统医学 呼吸系统医学
  • 药物开发 药物开发

背景情况:

  • 莱科特里因受体对抗剂代表了一类新的抗喘药物.
  • 这些药物提供一种独特的抗炎和支气管扩展性质的组合.
  • 方便的口服 (每天一次或两次) 是一个关键特征.

研究的目的:

  • 为了概述白血抗体的临床药理学.
  • 评估已发表的临床试验数据,以评估它们的疗效.
  • 确定这些药物在当前喘管理指南中的作用.

主要方法:

  • 审查已发表的临床试验数据.
  • 对药理学特征进行分析.
  • 对各种喘严重程度的疗效的评估.

主要成果:

  • 列可素受体对手表现出显著的抗喘活性.
  • 在单一治疗和与吸入类固醇联合治疗时观察到有效性.
  • 治疗过敏性鼻炎的潜在有效性,通常与喘并发.

结论:

更多相关视频

Use of Single Chain MHC Technology to Investigate Co-agonism in Human CD8+ T Cell Activation
12:09

Use of Single Chain MHC Technology to Investigate Co-agonism in Human CD8+ T Cell Activation

Published on: February 28, 2019

Isolation and Expansion of Cytotoxic Cytokine-induced Killer T Cells for Cancer Treatment
11:11

Isolation and Expansion of Cytotoxic Cytokine-induced Killer T Cells for Cancer Treatment

Published on: January 24, 2020

相关实验视频

Last Updated: Jul 5, 2026

Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries
08:49

Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries

Published on: January 22, 2019

Use of Single Chain MHC Technology to Investigate Co-agonism in Human CD8+ T Cell Activation
12:09

Use of Single Chain MHC Technology to Investigate Co-agonism in Human CD8+ T Cell Activation

Published on: February 28, 2019

Isolation and Expansion of Cytotoxic Cytokine-induced Killer T Cells for Cancer Treatment
11:11

Isolation and Expansion of Cytotoxic Cytokine-induced Killer T Cells for Cancer Treatment

Published on: January 24, 2020

  • 利可托里因受体对抗剂是具有有利特征的有效抗喘药物.
  • 它们的实用性延伸到同时存在的过敏性鼻炎的管理.
  • 这些药物值得在喘管理策略中考虑.